Acadia Healthcare Company, Inc. (ACHC)
NASDAQ: ACHC · Real-Time Price · USD
20.77
+0.44 (2.14%)
At close: Aug 13, 2025, 4:00 PM
20.06
-0.71 (-3.42%)
Pre-market: Aug 14, 2025, 9:01 AM EDT
Acadia Healthcare Company Stock Forecast
Stock Price Forecast
According to 9 professional analysts, the 12-month price target for Acadia Healthcare Company stock ranges from a low of $22 to a high of $75. The average analyst price target of $44.72 forecasts a 115.36% increase in the stock price over the next year.
Price Target: $44.72 (+115.36%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Acadia Healthcare Company stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 5 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 3 | 3 | 3 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 10 | 10 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Hold Maintains $32 → $22 | Hold | Maintains | $32 → $22 | +5.95% | Aug 14, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $43 → $28 | Buy | Maintains | $43 → $28 | +34.84% | Aug 13, 2025 |
| UBS | UBS | Strong Buy Maintains $45 → $31 | Strong Buy | Maintains | $45 → $31 | +49.29% | Aug 7, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $36 → $29 | Strong Buy | Maintains | $36 → $29 | +39.66% | Aug 7, 2025 |
| Barclays | Barclays | Hold Maintains $28 → $20 | Hold | Maintains | $28 → $20 | -3.68% | Aug 7, 2025 |
Financial Forecast
Revenue This Year
3.40B
from 3.15B
Increased by 7.80%
Revenue Next Year
3.69B
from 3.40B
Increased by 8.56%
EPS This Year
2.70
from 2.78
Decreased by -3.00%
EPS Next Year
2.97
from 2.70
Increased by 10.11%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.5B | 3.9B | 4.2B | ||
| Avg | 3.4B | 3.7B | 4.0B | ||
| Low | 3.2B | 3.5B | 3.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 12.0% | 13.7% | 13.1% | ||
| Avg | 7.8% | 8.6% | 7.4% | ||
| Low | 2.2% | 1.7% | 0.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.92 | 3.42 | 3.62 | ||
| Avg | 2.70 | 2.97 | 3.21 | ||
| Low | 2.33 | 2.37 | 2.50 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.0% | 26.9% | 22.0% | ||
| Avg | -3.0% | 10.1% | 8.0% | ||
| Low | -16.1% | -12.0% | -15.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.